Fig. 5

A two-step ?Vogelgram? model of deterministic and irreversible single-cell malignant transformation in vivo. Within a healthy tissue, a normal cell (in light gray) acquires (step 1) genetic mutation(s) in driver oncogene(s) (Mut-Drivers such as kRASG12V). Such a mutant cell (in blue, referred to as a preprocancer [Brash, 2015] cell) can (step 2) aberrantly activate the expression of Epi-Drivers involved in pluripotency/reprogramming (e.g. VENTX/NANOG, POU5/OCT4) thus undergoing deterministic and irreversible malignant cell transformation (red cell, the cell of origin of cancer); (step 3) in situ short-range dispersal of the early malignant cells and (step 4) further progression to cancer mass and to the appearance of metastatic cells. Inversely, the mutant (preprocancer) cell (in blue) can maintain its physiological functions and be eventually eliminated from the healthy tissue.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife